Triple-Negative Breast Cancer

Triple-negative breast cancer remains one of the most aggressive breast cancer subtypes. This session explores molecular mechanisms, diagnostic challenges, emerging biomarkers, and innovative treatment strategies. Experts will discuss immunotherapy, targeted therapies, and resistance mechanisms. Current clinical trials and future therapeutic directions will also be highlighted. The session aims to improve outcomes for this difficult-to-treat disease.

    Related Conference of Triple-Negative Breast Cancer

    July 23-24, 2026

    6th World Pathology Conference

    Amsterdam, Netherlands
    March 25-26, 2027

    25th European Pathology Congress

    Paris, France
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    Triple-Negative Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in